Rocket Lab (RKLB) got hit hard. The stock dropped nearly 11% on Wednesday, with volume surging to 2.4 times its daily average. That kind of action — heavy volume, sharp decline — usually means one thing: distribution. Institutions are selling.
The move pushed shares below the 20-day moving average at $124.91, a level that had held as support since the stock ripped higher in late May. Now that level flips to resistance. The 50-day moving average at $100.74 is the next logical floor.
Revenue is still ripping higher — up 63.5% year-over-year to $679.6 million. The space systems and launch services segments are both humming. The backlog is fat. Cash on the balance sheet is $1.38 billion against debt of just $139 million. On the fundamental side, the business is executing.
But the market is forward-looking, and the forward picture is expensive. The stock trades at roughly 94 times sales. Negative free cash flow of $215 million over the trailing twelve months means the company is still burning cash to scale. Neutron development costs are eating into margins.
The RSI-14 has dropped to 33.52, just above the oversold threshold of 30. That suggests selling pressure is exhausting itself, but it doesn’t mean a bounce is automatic. In breakdowns like this, the first bounce often gets sold into.
The technical structure is under pressure. The price has been making lower highs since the 52-week peak near $150. The move below the 20-day MA breaks the short-term trend. Bulls need to hold the 50-day moving average to keep the medium-term story intact.
Recent news flow has been mostly positive. Q3 revenue of $105.1 million beat consensus by about $2.3 million. Q4 guidance of $125-$135 million also topped estimates. The Air Force handed the company a $23.9 million contract for Archimedes engine development. Neutron is on track for a 2025 test launch from Wallops Island.
So why the sell-off? It could be profit-taking ahead of a catalyst — the Neutron debut — that is still over a year away. Or it could be rotation out of high-beta names as macro uncertainty ticks up. Whatever the cause, the chart is telling you to respect the breakdown.
Key Takeaways
Strengths
- Revenue growth of 63.5% YoY with strong backlog
- Net cash position of over $1.2 billion
- Diversified government and commercial contracts
Challenges
- Negative free cash flow and operating losses
- Extreme valuation at 94x sales
- Execution risk on Neutron rocket development
Analyst Note
The risk/reward here is balanced against an extremely high valuation. The company is executing well from a revenue and balance sheet standpoint, but the stock is pricing in perfection. A hold rating with a $100 price target reflects the potential for further downside toward the 50-day moving average if selling continues. The recent catalyst-driven sell-off should be respected, but the underlying business growth remains intact. A re-entry near $100 with a stop below the 200-day moving average offers a more favorable risk/reward profile.
This article is for informational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. BullReader has not received any compensation from the companies mentioned in this article. Always conduct your own research and consult a qualified financial adviser before making investment decisions.